Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model
- PMID: 39772217
- PMCID: PMC11680397
- DOI: 10.3390/v16121910
Understanding Perceptions of Hepatitis C and Its Management Among People with Experience of Incarceration in Quebec, Canada: A Qualitative Study Guided by the Common Sense Self-Regulation Model
Abstract
Hepatitis C virus (HCV) disproportionately affects certain sub-populations, including people with experience of incarceration (PWEI). Little is known about how perceptions of HCV and treatment have changed despite simplifications in testing and treatment in carceral settings. Nineteen semi-structured interviews were conducted with people living with or having a history of HCV infection released from Quebec provincial prison. Interviews were guided by the Common Sense Self-Regulation Model (CS-SRM) and aimed to explore cognitive and emotional representations of HCV and coping strategies. Among the 19 participants, seven (37%) were diagnosed with HCV in prison and 14 (74%) had previously received HCV treatment. Participants' HCV illness perceptions were influenced by fear (of HCV transmission, death, and the well-being of family) and stigma (related to HCV, injection drug use, and incarceration). While some sought education and social and professional support, others self-isolated or engaged in high-risk behaviors to cope. Despite advances in HCV treatment, PWEI continue to experience various forms of stigma and fear surrounding their HCV diagnosis, resulting in delayed HCV care. These findings provide insights into how prison-based healthcare providers can better utilize HCV illness perceptions to evaluate willingness to engage in HCV care among PWEI.
Keywords: CS-SRM; hepatitis C virus; implementation science; people with experience of incarceration; qualitative research.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: A.M., S.M., D.O.-P., A.P., G.F., C.D., J.M.G., and J.P. report no competing interests. J.C. has received research funding from ViiV Healthcare, Merck, and Gielead; consulting fees from ViiV Healthcare, Merck, and Gilead; and payment for lectures from Gilead, all outside this work. N.K. has received research funding from ViiV Healthcare, Abbvie, and Gilead; advisory fees from Gilead Sciences, ViiV Healthcare, Merck, and Abbvie; and speaker fees from Gilead Sciences, Abbvie, and Merck, all outside this work.
Figures
References
-
- World Health Organization Combating Hepatitis B and C to Reach Elimination by 2030. Advocacy Brief, 2016. [(accessed on 9 July 2024)]. Available online: https://iris.who.int/bitstream/handle/10665/206453/WHO_HIV_2016.04_eng.p....
-
- World Health Organization Global Health Sector Strategy on Viral Hepatitis 2016–2021: Towards Ending Viral Hepatitis. World Health Organization, 2016. [(accessed on 9 July 2024)]. Available online: https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-....
-
- Canadian Network on Hepatitis C Blueprint to Inform Hepatitis C Elimination Efforts in Canada, 2019. [(accessed on 9 July 2024)]. Available online: https://www.canhepc.ca/sites/default/files/media/documents/blueprint_hcv....
-
- Public Health Agency of Canada People living with Hepatitis C (HCV) in Canada—Canada.ca. Government of Canada, 2022. [(accessed on 9 July 2024)]. Available online: https://canada.ca/en/public-health/services/publications/diseases-condit....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
